Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Articles

Page Path
HOME > Diabetes Metab J > Volume 40(5); 2016 > Article
Response
Response: Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:297-307)
Jun Ouk Ha1, Tae Hee Lee2, Chang Won Lee1orcid
Diabetes & Metabolism Journal 2016;40(5):420-421.
DOI: https://doi.org/10.4093/dmj.2016.40.5.420
Published online: October 12, 2016
  • 2,653 Views
  • 32 Download
  • 2 Scopus

1Department of Internal Medicine, Busan St. Mary's Hospital, Busan, Korea.

2Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.

Corresponding author: Chang Won Lee. Department of Internal Medicine, Busan St. Mary's Hospital, 25-14, Yonghoro 232beon-gil, Nam-gu, Busan 48575, Korea. koje94@hanmail.net

Copyright © 2016 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

We thank Dr. Yi for his comments in response to our study, "Prevalence and risk factors of gastroesophageal reflux disease in patients with type 2 diabetes mellitus" [1]. Prevalence of gastroesophageal reflux disease (GERD) in Korea has gradually increased after westernized diet and lifestyle changes [2]. The prevalence of GERD in our study showed 32.6% in the type 2 diabetes mellitus (T2DM) group and 35.9% in the control group. We mentioned that the possibility of overestimation of the prevalence and symptoms of GERD cannot be ruled out by selection bias.
As Dr. Yi mentioned, esophageal pH monitoring and manometry are the gold standards for diagnosis of GERD and esophageal dysmotility [3]. Therefore, we agree that the application of pH monitoring and manometry in our study could possibly alter the prevalence of GERD. However, esophageal pH monitoring and manometry are not widely used compared with esophagogastroduodenoscopy (EGD) in real practice.
A recent meta-analysis by Sun et al. [4] identified a significant association between diabetes and risk of GERD. Although esophageal manometry and 24-hour pH monitoring are the gold standards for detecting GERD, the diagnosis of GERD in this study was established on the basis of reflux symptom questionnaires and the frequency of the cardinal symptoms [4]. Sun et al. [4] also mentioned several study limitations. Firstly, most of the included studies were cross-sectional. Secondly, there may be a certain selection bias. Finally, the data were not adjusted for body mass index. As pointed out by Dr. Yi, the prevalence of asymptomatic GERD confirmed by pH monitoring was significantly higher in diabetic patients than in healthy controls [5].
On the contrary to the meta-analysis and pH study, we concluded that the prevalence of GERD in patients with T2DM showed no difference from that of controls. In our study, we diagnosed as GERD when a patient had erosive esophagitis or nonerosive esophagitis with a frequency scale for symptoms of GERD score ≥8 and minimal change. A different diagnostic tool for GERD may oppositely affect the prevalence of GERD. We think the diagnostic method of GERD using EGD and symptoms is relatively objective compared with symptom-based diagnosis of GERD.
A recent research reported a higher prevalence of GERD symptoms among diabetes mellitus patients with neuropathy [6]. On the contrary, no significant correlation was observed between autonomic or peripheral neuropathy and GERD symptoms and occurrence in our study. Further studies that evaluate the diagnostic value of EGD and symptoms of GERD compared with pH monitoring and manometry in diabetic patients will be necessary in the future.
We appreciate Dr. Yi for the valuable comments and suggestions.

CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.

  • 1. Ha JO, Lee TH, Lee CW, Park JY, Choi SH, Park HS, Lee JS, Lee SH, Seo EH, Kim YH, Kang YW. Prevalence and risk factors of gastroesophageal reflux disease in patients with type 2 diabetes mellitus. Diabetes Metab J 2016;40:297-307. ArticlePubMedPMCPDF
  • 2. Shim CS. The diagnosis and treatment of GERD for family doctors. J Korean Acad Fam Med 2001;22:611-618.
  • 3. Boland BS, Edelman SV, Wolosin JD. Gastrointestinal complications of diabetes. Endocrinol Metab Clin North Am 2013;42:809-832. ArticlePubMedPMC
  • 4. Sun XM, Tan JC, Zhu Y, Lin L. Association between diabetes mellitus and gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol 2015;21:3085-3092. ArticlePubMedPMC
  • 5. Lluch I, Ascaso JF, Mora F, Minguez M, Pena A, Hernandez A, Benages A. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999;94:919-924. ArticlePubMed
  • 6. Wang X, Pitchumoni CS, Chandrarana K, Shah N. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol 2008;14:709-712. ArticlePubMedPMC

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • Cite
        CITE
        export Copy
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Response: Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:297-307)
        Diabetes Metab J. 2016;40(5):420-421.   Published online October 12, 2016
        Close
      • XML DownloadXML Download
      Related articles

      Diabetes Metab J : Diabetes & Metabolism Journal